Literature DB >> 22055714

Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand.

Abdol R Hajipour1, Lian-Wang Guo, Arindam Pal, Timur Mavlyutov, Arnold E Ruoho.   

Abstract

The sigma-2 (σ2) receptor has been suggested to be a promising target for pharmacological interventions to curb tumor progression. Development of σ2-specific ligands, however, has been hindered by lack of understanding of molecular determinants that underlie selective ligand-σ2 interactions. Here we have explored effects of electron donating and withdrawing groups on ligand selectivity for the σ2 versus σ1 receptor using new benzamide-isoquinoline derivatives. The electron-donating methoxy group increased but the electron-withdrawing nitro group decreased σ2 affinity. In particular, an extra methoxy added to the para-position (5e) of the benzamide phenyl ring of 5f dramatically improved (631 fold) the σ2 selectivity relative to the σ1 receptor. This para-position provided a sensitive site for effective manipulation of the sigma receptor subtype selectivity using either the methoxy or nitro substituent. Our study provides a useful guide for further improving the σ2-over-σ1 selectivity of new ligands.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22055714      PMCID: PMC3229200          DOI: 10.1016/j.bmc.2011.10.046

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  28 in total

Review 1.  Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo.

Authors:  Robert Henry Mach; Kenneth Theodore Wheeler
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2009-09

2.  A structure-affinity and comparative molecular field analysis of sigma-2 (sigma2) receptor ligands.

Authors:  Carmen Abate; Philip Daniel Mosier; Francesco Berardi; Richard A Glennon
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2009-09

3.  Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.

Authors:  Keith W Crawford; Wayne D Bowen
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

4.  Sigma 2 receptors as potential biomarkers of proliferation in breast cancer.

Authors:  R H Mach; C R Smith; I al-Nabulsi; B R Whirrett; S R Childers; K T Wheeler
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

5.  sigma(2) Receptors regulate changes in sphingolipid levels in breast tumor cells.

Authors:  Keith W Crawford; Andrew Coop; Wayne D Bowen
Journal:  Eur J Pharmacol       Date:  2002-05-17       Impact factor: 4.432

6.  Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

Review 7.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

8.  Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

Authors:  B J Vilner; C S John; W D Bowen
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

9.  CB-64D and CB-184: ligands with high sigma 2 receptor affinity and subtype selectivity.

Authors:  W D Bowen; C M Bertha; B J Vilner; K C Rice
Journal:  Eur J Pharmacol       Date:  1995-05-24       Impact factor: 4.432

10.  Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.

Authors:  Jinbin Xu; Chenbo Zeng; Wenhua Chu; Fenghui Pan; Justin M Rothfuss; Fanjie Zhang; Zhude Tu; Dong Zhou; Dexing Zeng; Suwanna Vangveravong; Fabian Johnston; Dirk Spitzer; Katherine C Chang; Richard S Hotchkiss; William G Hawkins; Kenneth T Wheeler; Robert H Mach
Journal:  Nat Commun       Date:  2011-07-05       Impact factor: 14.919

View more
  6 in total

1.  Development of benzophenone-alkyne bifunctional sigma receptor ligands.

Authors:  Lian-Wang Guo; Abdol R Hajipour; Kerim Karaoglu; Timur A Mavlyutov; Arnold E Ruoho
Journal:  Chembiochem       Date:  2012-09-23       Impact factor: 3.164

Review 2.  The σ2 receptor: a novel protein for the imaging and treatment of cancer.

Authors:  Robert H Mach; Chenbo Zeng; William G Hawkins
Journal:  J Med Chem       Date:  2013-06-18       Impact factor: 7.446

3.  New tetrahydroisoquinoline-based D3R ligands with an o-xylenyl linker motif.

Authors:  Pierpaolo Cordone; Hari K Namballa; Bryant Muniz; Rajat K Pal; Emilio Gallicchio; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2021-04-18       Impact factor: 2.940

4.  Synthesis and biological characterisation of 18F-SIG343 and 18F-SIG353, novel and high selectivity σ2 radiotracers, for tumour imaging properties.

Authors:  Vu H Nguyen; Tien Pham; Chris Fookes; Paula Berghofer; Ivan Greguric; Andrew Arthur; Filomena Mattner; Gita Rahardjo; Emma Davis; Nicholas Howell; Marie-Claude Gregoire; Andrew Katsifis; Rachael Shepherd
Journal:  EJNMMI Res       Date:  2013-12-11       Impact factor: 3.138

Review 5.  Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.

Authors:  Markos-Orestis Georgiadis; Olga Karoutzou; Angeliki-Sofia Foscolos; Ioannis Papanastasiou
Journal:  Molecules       Date:  2017-08-25       Impact factor: 4.411

6.  QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs.

Authors:  Yangxi Yu; Hiep Dong; Youyi Peng; William J Welsh
Journal:  Molecules       Date:  2021-08-30       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.